ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 88 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.87 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $457,000 | +9.3% | 20,075 | -28.0% | 0.02% | -4.2% |
| Q2 2019 | $418,000 | +2.0% | 27,875 | +19.3% | 0.02% | -4.0% |
| Q1 2019 | $410,000 | +175.2% | 23,375 | +132.0% | 0.02% | +150.0% |
| Q4 2018 | $149,000 | -68.6% | 10,075 | -58.3% | 0.01% | -47.4% |
| Q2 2018 | $474,000 | -74.3% | 24,156 | -75.5% | 0.02% | -74.3% |
| Q1 2018 | $1,847,000 | – | 98,544 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |